Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:694179.
doi: 10.1155/2011/694179. Epub 2011 Oct 12.

Autoradiographic Mapping of 5-HT(1B/1D) Binding Sites in the Rhesus Monkey Brain Using [carbonyl-C]zolmitriptan

Affiliations

Autoradiographic Mapping of 5-HT(1B/1D) Binding Sites in the Rhesus Monkey Brain Using [carbonyl-C]zolmitriptan

Orjan Lindhe et al. Int J Mol Imaging. 2011.

Abstract

Zolmitriptan is a serotonin 5-HT(1B/1D) receptor agonist that is an effective and well-tolerated drug for migraine treatment. In a human positron emission tomography study, [(11)C]zolmitriptan crossed the blood-brain barrier but no clear pattern of regional uptake was discernable. The objective of this study was to map the binding of [(11)C]zolmitriptan in Rhesus monkey brain using whole hemisphere in vitro autoradiography with [(11)C]zolmitriptan as a radioligand. In saturation studies, [(11)C]zolmitriptan showed specific (90%) binding to a population of high-affinity binding sites (Kd 0.95-5.06 nM). There was regional distribution of binding sites with the highest density in the ventral pallidum, followed by the external globus pallidus, substantia nigra, visual cortex, and nucleus accumbens. In competitive binding studies with 5-HT(1) receptor antagonists, [(11)C]zolmitriptan binding was blocked by selective 5-HT(1B) and 5-HT(1D) ligands in all target areas. There was no appreciable change in binding with the addition of a 5-HT(1A) receptor antagonist.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preparation of [carbonyl-11C]zolmitriptan.
Figure 2
Figure 2
Color-coded autoradiograms showing Rhesus monkey whole-hemisphere autoradiography using [11C]zolmitriptan. (a) Schematic drawings of the Rhesus monkey brain according to Paxinos et al. [19] to show the anterior-posterior position of the selected coronal tissue sections; (b) corresponding tissue sections; (c) autoradiograms; (d) superimposed autoradiograms and corresponding tissue sections for better anatomical localization of [11C]zolmitriptan binding.
Figure 3
Figure 3
Color-coded autoradiograms of [11C]zolmitriptan (top) and [11C]WAY 100635 (bottom) on consecutive brain sections, comparing the distribution of binding sites for the respective tracer. Numbers identify sections where strong [11C]zolmitriptan binding is observed. (1) Nucleus accumbens, (2) Ventral pallidum and external globus pallidus (3) Substantia nigra, and (4) Visual cortex. Note the minimal overlap of tracer binding sites.

Similar articles

Cited by

References

    1. Goadsby PJ. The pharmacology of headache. Progress in Neurobiology. 2000;62(5):509–525. - PubMed
    1. Martin GR, Robertson AD, MacLennan SJ, et al. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT(1B/1D) receptor partial agonist, 311C90 (zolmitriptan) British Journal of Pharmacology. 1997;121(2):157–164. - PMC - PubMed
    1. Goadsby PJ, Edvinsson L. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache. 1994;34(7):394–399. - PubMed
    1. Goadsby PJ, Hoskin KL. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)(1B/D) receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain. 1996;67(2-3):355–359. - PubMed
    1. Goadsby PJ, Knight YE. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia. 1997;17(3):153–158. - PubMed

LinkOut - more resources